Navigation Links
Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO

Madison, Wis. - In a merging of complementary companies, Cytochroma, Inc., a Canadian firm seeking to commercialize new Vitamin D products, has acquired Proventiv Therapeutics, LLC, of Madison, and the combined company is looking for an additional $25 million in venture capital from Canadian and American investors.

Proventiv was founded in Se......

Full article >>> are employee Keith H. Crawford, who will be vice president of strategic planning for Cytochroma.

Jay A. White, the new vice president of product development, is the former vice president of operations at Cytochroma.

Continuing in their present roles will be Martin Petkovich, chief scientific officer, and Jukka K. Karjalainen, vice president of clinical affairs.

Rae, Cyt......

Full article >>> F's goals," Block said in a statement.

......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 06/29/06


Related biology technology :

1. GE Healthcare enters agreement with Canadian health authority
2. Canadian firm acquires Silicon Logic
3. Take off: Canadian biotech industry thrives
4. Merge eFilm corporate merger with Canadian firm moves ahead
5. Standard Imaging acquires Canadian PIPSpro radiation treatment technologies
6. Standard Imaging acquires Canadian PIPSpro radiation treatment technologies
7. EraGen signs Canadian Market Distribution Agreement for nucleic acid dection products
8. BIO 2007: Wisconsin makes its presence felt
9. Tired of the spin? ExpertVoter website makes candidate selection easier
10. Whitewater makes plans for business incubator
11. Online service makes board connections
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... 2016 , ... KBioBox llc announced today the launch of ... a sophisticated “3 click” gene dditing off target analysis program and a “3 ... https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. Scientists, pharmaceutical researchers ...
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. ... biopharmaceutical company focused on developing and commercializing products ... unmet medical need, announced today the long-term follow-up ... SGX942 (dusquetide), a first-in-class Innate Defense Regulator (IDR), ... head and neck cancer patients undergoing chemoradiation therapy ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. ... billion KRW (US $18.9M) Series A financing. This financing ... G.N. Tech Venture and SNU Bio Angel. This new ... 30.5 billion KRW (US $27.7M) since its founding in ... to bolster the development and commercialization of its immuno-oncology ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... has concluded that “in the setting of previously treated, advanced pancreatic cancer, liquid ... defining the optimal patient population and timing of blood sampling may improve the ...
Breaking Biology Technology:
(Date:11/28/2016)... 28, 2016 "The biometric ... 16.79%" The biometric system market is in the ... the near future. The biometric system market is expected ... at a CAGR of 16.79% between 2016 and 2022. ... biometric technology in smartphones, rising use of biometric technology ...
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... Medical LiveWire Healthcare and Life Sciences Awards as ... caps off an unprecedented year of recognition and growth ... for over 15 years. iMedNet ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):